RCMU
CRGX

Rokos Capital Management (UK)’s CARGO Therapeutics CRGX Stock Holding History

Rokos Capital Management (UK)’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100,000
Closed -$2.31M – 95
2023
Q4 		$2.31M Buy
+100,000
New +$1.7M 0.02% 64

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Rokos Capital Management (UK)'s CRGX Position: Q1 2024 in Review

Rokos Capital Management (UK) sold out of CARGO Therapeutics (CRGX) in Q1 2024, closing a stake of 100,000 shares — an estimated $2.31M sold.

Rokos Capital Management (UK) first reported a position in CRGX in Q4 2023 and held it in 1 quarter. The position peaked at $2.31M in Q4 2023. 65 funds tracked by Wall St. Rank hold CRGX as of Q1 2024.

  • Rokos Capital Management (UK) reported no remaining CARGO Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 100,000 CARGO Therapeutics shares in Q1 2024, an estimated $2.31M.
  • Rokos Capital Management (UK) first reported a position in CARGO Therapeutics in Q4 2023 and held it in 1 quarter.
  • Rokos Capital Management (UK)'s CARGO Therapeutics position peaked at $2.31M in Q4 2023.
  • 65 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2024.

Based on Rokos Capital Management (UK)'s 13F filing for Q1 2024, filed 15 May 2024.